Literature DB >> 28284384

Autosomal Dominant Tubulointerstitial Kidney Disease.

Anthony J Bleyer1, Kendrah Kidd2, Martina Živná2, Stanislav Kmoch2.   

Abstract

There are 3 major forms of autosomal dominant tubulointerstitial kidney disease (ADTKD): ADTKD due to UMOD mutations, MUC1 mutations, and mutations in the REN gene encoding renin. Lack of knowledge about these conditions contributes to frequent nondiagnosis, but with even limited knowledge, nephrologists can easily obtain a diagnosis and improve patient care. There are 3 cardinal features of these disorders: (1) the conditions are inherited in an autosomal dominant manner and should be considered whenever both a parent and child suffer from kidney disease; the presence of even more affected family members provides further support. (2) These conditions are associated with a bland urinary sediment, ruling out glomerular disorders. (3) There is a variable rate of decline in kidney function. The mean age of ESRD is approximately 45, but the range is from 17 to >75. ADTKD-UMOD is often but not always associated with gout in the teenage years. ADKTKD-REN is associated with signs of hyporeninemia: mild hypotension, mild hyperkalemia, anemia in childhood, and hyperuricemia and gout in the teenage years. The only clinical manifestation of ADTKD-MUC1 is slowly progressive CKD. Diagnosis should be made by genetic testing, and kidney biopsy should be avoided.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autosomal dominant; Mucin-1; Renin; Tubulointerstitial; Uromodulin

Mesh:

Substances:

Year:  2017        PMID: 28284384      PMCID: PMC5488707          DOI: 10.1053/j.ackd.2016.11.012

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  36 in total

1.  Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.

Authors:  Kerim Mutig; Thomas Kahl; Turgay Saritas; Michael Godes; Pontus Persson; James Bates; Hajamohideen Raffi; Luca Rampoldi; Shinichi Uchida; Carsten Hille; Carsten Dosche; Satish Kumar; Maria Castañeda-Bueno; Gerardo Gamba; Sebastian Bachmann
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

2.  Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene.

Authors:  Anthony J Bleyer; Arch S Woodard; Zak Shihabi; Jaspreet Sandhu; Honping Zhu; Scott G Satko; Nelson Weller; Elizabeth Deterding; Debra McBride; Michael C Gorry; Linda Xu; Deann Ganier; Thomas C Hart
Journal:  Kidney Int       Date:  2003-07       Impact factor: 10.612

3.  Biosynthesis and oligosaccharide processing of human Tamm-Horsfall glycoprotein permanently expressed in HeLa cells.

Authors:  F Serafini-Cessi; N Malagolini; T C Hoops; M J Rindler
Journal:  Biochem Biophys Res Commun       Date:  1993-07-30       Impact factor: 3.575

4.  Hepatocyte nuclear factor 1β controls nephron tubular development.

Authors:  Filippo Massa; Serge Garbay; Raymonde Bouvier; Yoshinobu Sugitani; Tetsuo Noda; Marie-Claire Gubler; Laurence Heidet; Marco Pontoglio; Evelyne Fischer
Journal:  Development       Date:  2013-02       Impact factor: 6.868

5.  The syndrome of hypoparathyroidism, deafness, and renal anomalies.

Authors:  Jagriti Upadhyay; Devin W Steenkamp; Jeff M Milunsky
Journal:  Endocr Pract       Date:  2013 Nov-Dec       Impact factor: 3.443

6.  Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  Hendrica Belge; Karin Dahan; Jean-François Cambier; Valérie Benoit; Johann Morelle; Julie Bloch; Philippe Vanhille; Yves Pirson; Nathalie Demoulin
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

7.  The serine protease hepsin mediates urinary secretion and polymerisation of Zona Pellucida domain protein uromodulin.

Authors:  Martina Brunati; Simone Perucca; Ling Han; Angela Cattaneo; Francesco Consolato; Annapaola Andolfo; Céline Schaeffer; Eric Olinger; Jianhao Peng; Sara Santambrogio; Romain Perrier; Shuo Li; Marcel Bokhove; Angela Bachi; Edith Hummler; Olivier Devuyst; Qingyu Wu; Luca Jovine; Luca Rampoldi
Journal:  Elife       Date:  2015-12-17       Impact factor: 8.140

Review 8.  Alagille syndrome: clinical perspectives.

Authors:  Maha Saleh; Binita M Kamath; David Chitayat
Journal:  Appl Clin Genet       Date:  2016-06-30

9.  Technical report: Ethical and policy issues in genetic testing and screening of children.

Authors:  Lainie Friedman Ross; Laine Friedman Ross; Howard M Saal; Karen L David; Rebecca R Anderson
Journal:  Genet Med       Date:  2013-02-21       Impact factor: 8.822

10.  Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.

Authors:  Olivier Devuyst; Luca Rampoldi; Matteo Trudu; Sylvie Janas; Chiara Lanzani; Huguette Debaix; Céline Schaeffer; Masami Ikehata; Lorena Citterio; Sylvie Demaretz; Francesco Trevisani; Giuseppe Ristagno; Bob Glaudemans; Kamel Laghmani; Giacomo Dell'Antonio; Johannes Loffing; Maria P Rastaldi; Paolo Manunta
Journal:  Nat Med       Date:  2013-11-03       Impact factor: 53.440

View more
  16 in total

1.  Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Authors:  Kotaro Yoshida; Naoki Takahashi; Bernard F King; Akira Kawashima; Peter C Harris; Lynn D Cornell; Emilie Cornec-Le Gall; Dai Inoue; Ichiro Mizushima; Mitsuhiro Kawano; Eric Thervet; Paul René de Cotret; Vicente E Torres
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

Review 2.  Novel roles for mucin 1 in the kidney.

Authors:  Mohammad M Al-Bataineh; Timothy A Sutton; Rebecca P Hughey
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-09       Impact factor: 2.894

3.  Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females.

Authors:  Marie Zikánová; Dawn Wahezi; Arielle Hay; Blanka Stiburková; Charles Pitts; Dita Mušálková; Václava Škopová; Veronika Barešová; Olga Soucková; Katerina Hodanová; Martina Živná; Viktor Stránecký; Hana Hartmannová; Ales Hnízda; Anthony J Bleyer; Stanislav Kmoch
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

4.  Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Martina Živná; Kendrah Kidd; Anna Přistoupilová; Veronika Barešová; Mathew DeFelice; Brendan Blumenstiel; Maegan Harden; Peter Conlon; Peter Lavin; Dervla M Connaughton; Hana Hartmannová; Kateřina Hodaňová; Viktor Stránecký; Alena Vrbacká; Petr Vyleťal; Jan Živný; Miroslav Votruba; Jana Sovová; Helena Hůlková; Victoria Robins; Rebecca Perry; Andrea Wenzel; Bodo B Beck; Tomáš Seeman; Ondřej Viklický; Sylvie Rajnochová-Bloudíčková; Gregory Papagregoriou; Constantinos C Deltas; Seth L Alper; Anna Greka; Anthony J Bleyer; Stanislav Kmoch
Journal:  J Am Soc Nephrol       Date:  2018-07-02       Impact factor: 10.121

5.  Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Siu Chiu Chan; Ying Zhang; Annie Shao; Svetlana Avdulov; Jeremy Herrera; Karam Aboudehen; Marco Pontoglio; Peter Igarashi
Journal:  J Am Soc Nephrol       Date:  2018-08-10       Impact factor: 10.121

Review 6.  Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Authors:  Anthony J Bleyer; Matthias T Wolf; Kendrah O Kidd; Martina Zivna; Stanislav Kmoch
Journal:  Pediatr Nephrol       Date:  2021-05-22       Impact factor: 3.651

7.  Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.

Authors:  L B Lopes; C C Abreu; C F Souza; L E R Guimaraes; A A Silva; F Aguiar-Alves; K O Kidd; S Kmoch; A J Bleyer; J R Almeida
Journal:  Braz J Med Biol Res       Date:  2018-03-01       Impact factor: 2.590

Review 8.  Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.

Authors:  Annie Shao; Siu Chiu Chan; Peter Igarashi
Journal:  Cell Signal       Date:  2020-02-14       Impact factor: 4.315

9.  Challenging Disease Ontology by Instances of Atypical PKHD1 and PKD1 Genetics.

Authors:  Jonathan de Fallois; Ria Schönauer; Johannes Münch; Mato Nagel; Bernt Popp; Jan Halbritter
Journal:  Front Genet       Date:  2021-06-25       Impact factor: 4.599

10.  Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.

Authors:  Christine Gast; Anthony Marinaki; Monica Arenas-Hernandez; Sara Campbell; Eleanor G Seaby; Reuben J Pengelly; Daniel P Gale; Thomas M Connor; David J Bunyan; Kateřina Hodaňová; Martina Živná; Stanislav Kmoch; Sarah Ennis; G Venkat-Raman
Journal:  BMC Nephrol       Date:  2018-10-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.